Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing natalizumab (medicinal product) | Is a | Product containing alpha-4 integrin receptor antagonist (product) | true | Inferred relationship | Some | ||
| Product containing natalizumab (medicinal product) | Is a | Product containing monoclonal antibody (product) | true | Inferred relationship | Some | ||
| Product containing natalizumab (medicinal product) | Has active ingredient | Natalizumab (substance) | true | Inferred relationship | Some | 1 | |
| Product containing natalizumab (medicinal product) | Is a | Inflammatory bowel disease drug | false | Inferred relationship | Some | ||
| Product containing natalizumab (medicinal product) | Is a | murin-human monoklonal IgG-antikropp | false | Inferred relationship | Some | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| natalizumab 300 mg injektionsvätska, lösning, flaska 15 ml | Is a | False | Product containing natalizumab (medicinal product) | Inferred relationship | Some | |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | Is a | False | Product containing natalizumab (medicinal product) | Inferred relationship | Some | |
| Natalizumab-containing product in parenteral dose form | Is a | True | Product containing natalizumab (medicinal product) | Inferred relationship | Some | |
| Product containing only natalizumab (medicinal product) | Is a | True | Product containing natalizumab (medicinal product) | Inferred relationship | Some | 
This concept is not in any reference sets